Brand

Hims & Hers

Hims & Hers is a publicly traded (NYSE: HIMS) multi-specialty telehealth and DTC wellness platform founded in 2017, offering prescription medications, OTC products, supplements, and lab testing across the US, UK, Canada, and Europe. It operates at the intersection of health and retail, with products available through its app, website, and retail partnerships including Target.

Products & Services

AI companion for GLP-1 adherence (announced Q1 2026)Labs AI biomarker-interpretation agentMedMatch AI/ML treatment-matching platformAI weight-loss companion (agentic retention layer)GLP-1 telehealth subscriptionWegovy branded resale

Coverage in Rack & Reason (2)

First mentioned: May 2026